UPLOAD Filing
CERO THERAPEUTICS HOLDINGS, INC.
Date: Aug. 14, 2025 · CIK: 0001870404 · Accession: 0000000000-25-008554
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-289459
Letter
Re: CERo Therapeutics Holdings, Inc. Registration Statement on Form S-3 Filed August 11, 2025 File No. 333-289459 Dear Chris Ehrlich:
August 14, 2025
Chris Ehrlich Chief Executive Officer CERo Therapeutics Holdings, Inc. 201 Haskins Way, Suite 230 South San Francisco, CA 94080
This is to advise you that we have not reviewed and will not review your registration statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Tim Buchmiller at 202-551-3635 with any questions.
Sincerely,
Division of
Corporation Finance
Office of Life
Sciences
cc: Jeffrey A. Letalien, Esq.
Show Raw Text
<DOCUMENT> <TYPE>TEXT-EXTRACT <SEQUENCE>2 <FILENAME>filename2.txt <TEXT> August 14, 2025 Chris Ehrlich Chief Executive Officer CERo Therapeutics Holdings, Inc. 201 Haskins Way, Suite 230 South San Francisco, CA 94080 Re: CERo Therapeutics Holdings, Inc. Registration Statement on Form S-3 Filed August 11, 2025 File No. 333-289459 Dear Chris Ehrlich: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Tim Buchmiller at 202-551-3635 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Jeffrey A. Letalien, Esq. </TEXT> </DOCUMENT>